Intravesical administration of bacillus Calmette-Guerin in patients with recurrent superficial carcinoma of the urinary bladder: Report of a prospective, randomized trial Journal Article


Authors: Pinsky, C. M.; Camacho, F. J.; Kerr, D.; Geller, N. L.; Klein, F. A.; Herr, H. A.; Whitmore, W. F. Jr; Oettgen, H. F.
Article Title: Intravesical administration of bacillus Calmette-Guerin in patients with recurrent superficial carcinoma of the urinary bladder: Report of a prospective, randomized trial
Abstract: In an attempt to prevent, delay, or reduce further tumor occurrence, 88 patients with recurrent, superfical carcinoma of the urinary bladder were randomly assigned to receive either standard therapy (cystoscopy with fulguration) or standard therapy and bacillus Calmette-Guerin (BCG). BCG was administered intravesically and percutaneously once weekly for 6 weeks. No serious toxicity was seen. There were 43 evaluable patients in each of the two groups. Results in the BCG group versus the control group were as follows: reduction in the number of recurrent tumors (43 vs 27 patients [P < 0.001]); conversion to negative cytology (11 of 33 vs three of 34 patients [P < 0.05]; and tumor progression requiring cystectomy (three vs 15 patients [P < 0.001]). Disease-free interval (P < 0.001), time with negative cytology (P < 0.001), and time to progression of disease (P < 0.003) were longer in patients treated with BCG. These results indicate that the combination of standard therapy and BCG is more effective than standard therapy alone in patients with recurrent superficial bladder tumors.
Keywords: adult; clinical article; aged; middle aged; cancer recurrence; combined modality therapy; follow-up studies; prospective studies; bcg vaccine; cancer immunotherapy; neoplasm recurrence, local; carcinoma, papillary; urinary bladder neoplasms; fever; carcinoma in situ; diagnosis; cystoscopy; papilloma; drug therapy; toxicity; bladder carcinoma; therapy; clinical trials; hydronephrosis; bladder; random allocation; prostatitis; trial; intoxication; skin tests; humans; human; male; female; priority journal
Journal Title: Cancer Treatment Reports
Volume: 69
Issue: 1
ISSN: 0361-5960
Publisher: National Cancer Institute  
Date Published: 1985-01-01
Start Page: 47
End Page: 53
Language: English
PUBMED: 3881177
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 26 October 2021 -- Source: Scopus
Citation Impact
MSK Authors
  1. Herbert F Oettgen
    130 Oettgen
  2. Willet F. Whitmore Jr
    139 Whitmore
  3. Nancy L. Geller
    65 Geller